Related Experiment Video
Updated: Jun 21, 2026

Bilateral Common Carotid Artery Occlusion as an Adequate Preconditioning Stimulus to Induce Early Ischemic Tolerance to Focal Cerebral Ischemia
Published on: May 9, 2013
Beyond Pharmacology: The Biological Mechanisms of Remote Ischemic Conditioning in Cerebrovascular Disease
Linhui Qin1, Fang Tong1, Sijie Li1
1Beijing Key Laboratory of Hypoxia Conditioning Translational Medicine, Xuanwu Hospital, Capital Medical University, Beijing 100053, China.
Insights
Remote ischemic conditioning (RIC) offers a non-drug approach to protect the brain from cerebrovascular diseases (CVDs) like stroke. This method activates natural defenses, aiding recovery and potentially enhancing other treatments.
Area of Science:
- Neuroscience
- Cardiovascular Research
- Regenerative Medicine
Background:
- Cerebrovascular diseases (CVDs), including stroke and chronic cerebral hypoperfusion (CCH), are leading causes of death and disability worldwide.
- Current treatments for CVDs have limitations, highlighting the need for novel therapeutic strategies.
- Remote ischemic conditioning (RIC) is a non-pharmacological intervention showing promise for neuroprotection.
Purpose of the Study:
- To review the neuroprotective mechanisms of RIC in the context of cerebrovascular diseases.
- To explore the efficacy of RIC during acute and chronic phases of stroke recovery.
- To investigate the synergistic effects of RIC with other therapies and its peripheral transmission pathways.
Main Methods:
- Comprehensive literature review of studies on remote ischemic conditioning and cerebrovascular diseases.
- Analysis of neuroprotective mechanisms, including acute and chronic effects post-stroke.
- Examination of combined therapeutic strategies and peripheral signaling pathways.
Main Results:
- RIC activates endogenous defense mechanisms conferring neuroprotection against CVDs.
- RIC demonstrates benefits in both acute stroke management and chronic recovery phases.
- Synergistic effects observed when RIC is combined with pharmacological treatments and exercise.
Conclusions:
- RIC is a promising non-pharmacological strategy for managing cerebrovascular diseases.
- Further research is needed to standardize RIC protocols and identify biomarkers.
- Expanded clinical trials are essential to validate RIC's therapeutic potential and guide clinical application.
Abstract:
Cerebrovascular diseases (CVDs), comprising predominantly ischemic stroke and chronic cerebral hypoperfusion (CCH), are a significant threat to global health, often leading to disability and mortality. Remote ischemic conditioning (RIC) has emerged as a promising, non-pharmacological strategy to combat CVDs by leveraging the body's innate defense mechanisms. This review delves into the neuroprotective mechanisms of RIC, categorizing its effects during the acute and chronic phases of stroke recovery. It also explores the synergistic potential of RIC when combined with other therapeutic strategies, such as pharmacological treatments and physical exercise. Additionally, this review discusses the pathways through which peripheral transmission can confer central neuroprotection. This review concludes by addressing the challenges regarding and future directions for RIC, emphasizing the need for standardized protocols, biomarker identification, and expanded clinical trials to fully realize its therapeutic potential.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology

